Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
ALS Research Reauthorization with Transparent Safety Review
Generated by VFA SI Solutions
The proposal retains the existing ALS research and patient-access research pathways, adds review of safety and available efficacy data, and makes program outcomes clearer to patients and Congress. It keeps the current $100 million annual authorization instead of raising it,…
Path: Members in both chambers who favor ALS research and patient access may support the extension and safety review, while members focused on spending and administrative burden may scrutinize the…
→ Read full solution